Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Scientific Reports|April 21, 2024
Salvage prostate intensity modulated radiation therapy after cryotherapy failureTanguy Perennec, Maximilien Rogé, Jean-François Hetet, et al.Cancers|August 26, 2023
Cardiologist-Performed Baseline Evaluation with an Assessment of Coronary Status for Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Impact on Newly Diagnosed Coronary Artery DiseaseMaximilien Rogé, Valentine Guimas, Emmanuel Rio, et al.Brachytherapy|June 19, 2016
Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?Valentine Guimas, Magali Quivrin, Aurélie Bertaut, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2026
Cumulative dose analysis following elective pelvis re-irradiation at junction with primary prostate radiotherapy from the OLIGOPELVIS GETUG P07 trialLoïg Vaugier, Sophie Chiavassa, Anthony Alexis, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2025
Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologiqueYuedan Zhou, Alexandre Escande, David Pasquier, et al.Cancers|April 16, 2020
Haute Couture or Ready-to-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node DetectionAnne-Victoire Michaud, Benoit Samain, Ludovic Ferrer, et al.International Journal of Radiation Oncology, Biology, Physics|September 29, 2022
Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple MyelomaAxel Cailleteau, Philippe Maingon, Sylvain Choquet, et al.Critical Reviews in Oncology/Hematology|July 28, 2026
Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR groupJérémy Mercier, Pierre Cornillon, Philippe Barthélémy, et al.European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.Clinical and Translational Radiation Oncology|March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocolMaximilien Rogé, Yoann Pointreau, Paul Sargos, et al.Pageof 3